Labeling of Certain Household Products Containing Methylene Chloride; Supplemental Guidance, 12254-12259 [2018-05580]
Download as PDF
12254
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
smooth, appropriate to the phase of
flight and type of maneuver, and not in
conflict with the ability of the pilot to
satisfactorily change airplane flight
path, speed, or attitude as needed.
b. Limit values of protected flight
parameters (and if applicable, associated
warning thresholds) must be compatible
with the following:
i. Airplane structural limits,
ii. Required safe and controllable
maneuvering of the airplane, and
iii. Margins to critical conditions.
Unsafe flight characteristics/conditions
must not result if dynamic
maneuvering, airframe and system
tolerances (both manufacturing and inservice), and non-steady atmospheric
conditions, in any appropriate
combination and phase of flight, can
produce a limited flight parameter
beyond the nominal design-limit value.
c. The airplane must be responsive to
intentional dynamic maneuvering to
within a suitable range of the parameter
limit. Dynamic characteristics such as
damping and overshoot must also be
appropriate for the flight maneuver and
limit parameter in question.
d. When simultaneous envelope
limiting is engaged, adverse coupling or
adverse priority must not result.
Failure States
a. Electronic flight-control-system
failures (including sensors) must not
result in a condition where a parameter
is limited to such a reduced value that
safe and controllable maneuvering is no
longer available.
b. The crew must be alerted by
suitable means if any change in
envelope limiting or maneuverability is
produced by single or multiple failures
of the electronic flight-control system
not shown to be extremely improbable.
Issued in Des Moines, Washington, on
March 15, 2018.
Victor Wicklund,
Manager, Transport Standards Branch, Policy
and Innovation Division, Aircraft
Certification Service.
[FR Doc. 2018–05662 Filed 3–20–18; 8:45 am]
BILLING CODE 4910–13–P
CONSUMER PRODUCT SAFETY
COMMISSION
sradovich on DSK3GMQ082PROD with RULES
16 CFR Chapter II
[Docket No. CPSC–2016–2019]
Labeling of Certain Household
Products Containing Methylene
Chloride; Supplemental Guidance
Consumer Product Safety
Commission.
AGENCY:
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
ACTION:
Guidance.
The Halogenated Solvents
Industry Alliance petitioned the
Consumer Product Safety Commission
to amend its 1987 policy statement
regarding the labeling of certain
products containing methylene chloride
to address acute hazards from inhaling
methylene chloride vapors in addition
to the chronic hazards addressed in the
policy statement. In this document, the
Commission updates the 1987 policy
statement to provide guidance regarding
the labeling to warn of acute hazards
associated with paint strippers
containing methylene chloride.
DATES: This guidance document
becomes applicable on March 21, 2018.
FOR FURTHER INFORMATION CONTACT:
Carol Afflerbach, Office of Compliance
and Field Operations, U.S. Consumer
Product Safety Commission; 4330 EastWest Highway, Bethesda, MD 20814;
email: cafflerbach@cpsc.gov; telephone:
(301) 504–7529.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
In 1987, the U.S. Consumer Product
Safety Commission (CPSC or
Commission) issued a Statement of
Interpretation and Enforcement Policy
regarding the labeling of certain
household products containing
methylene chloride (1987 Statement), 52
FR 34698 (Sept. 14, 1987). The 1987
Statement noted that the Commission
considers certain household products
containing methylene chloride (DCM) to
be ‘‘hazardous substances’’ under the
FHSA and may pose a risk of
carcinogenicity. The 1987 Statement
identified several categories of products
that contained methylene chloride that
could expose consumers to significant
amounts of methylene chloride vapor,
and were thus hazardous substances.
Paint strippers were one of these
product categories. The 1987 Statement
advised manufacturers of the FHSA’s
labeling requirements and provided
guidance for labeling those products,
including paint strippers, to warn of the
cancer risk from inhaling methylene
chloride vapor.
On July 7, 2016, the Halogenated
Solvents Industry Alliance (HSIA or
petitioner) petitioned the CPSC to
amend its 1987 Statement to recognize
the acute hazard posed by using
household products containing DCM in
enclosed spaces with inadequate
ventilation. The petitioner stated that
using household products containing
DCM in bathrooms, or other enclosed
spaces, with inadequate ventilation can
be dangerous. When consumers use
PO 00000
Frm 00008
Fmt 4700
Sfmt 4700
methylene chloride to strip coatings
from bathtubs, they often spray or pour
a bathtub stripping product into the
basin of the bathtub and then brush the
product onto the tub surface. Many of
these stripping products contain
substantial amounts of methylene
chloride. According to the petitioner,
methylene chloride is a volatile organic
compound that will evaporate quickly
when sprayed, brushed, or poured, so
that its vapor can quickly build up in
small spaces. The petitioner stated that
DCM has a high vapor pressure, which
causes vapors to collect in the bottom of
a bathtub and in a consumer’s breathing
zone when working in a bathtub. This
situation can create dangerously high
concentrations of DCM, and in some
cases, replace the breathable air. The
petitioner asked the Commission to
expand the cautionary labeling guidance
so that it also warns of the threat of
asphyxiation if DCM-based paint
strippers are used in an enclosed space.
CPSC staff prepared a briefing
package in response to the petition and
submitted the package to the
Commission on May 26, 2017. On June
2, 2017, the Commission voted
unanimously (5–0) to grant the petition
(HP 16–1) and directed CPSC staff to
draft a policy statement that addresses
labeling for acute hazards from inhaling
methylene chloride vapors from paint
strippers.
II. EPA Rulemaking
The EPA has initiated rulemaking
under section 6(a) of the Toxic
Substances Control Act (TSCA) to
address risks posed by DCM when used
in paint and coating removal products.
Specifically, EPA has issued a proposed
rule that provides an assessment of the
health hazards posed by DCM and that
proposes to determine that DCM in
these products presents an unreasonable
risk of injury to health. Based on this
determination, and after considering
regulatory alternatives, EPA proposed to
prohibit the manufacture (including
import), processing, and distribution in
commerce of DCM for all consumer and
most commercial paint removal
products, and to prohibit commercial
use. 82 FR 7464 (Jan. 19, 2017). EPA’s
rulemaking would address both
consumer and worker exposures to DCM
used for paint and coating removal.
While developing its rulemaking, EPA
consulted with CPSC staff. Under EPA’s
rulemaking (if finalized as proposed),
paint and coating removal products
containing DCM would no longer be on
the market for consumers or commercial
workers, except in limited
circumstances. To date, EPA has not
finalized its rulemaking. Accordingly,
E:\FR\FM\21MRR1.SGM
21MRR1
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
the Commission believes that updating
CPSC’s 1987 Statement would provide
more immediate guidance and clarity to
industry and consumers regarding the
acute hazards associated with using
DCM-containing paint strippers while
those products remain on the market. By
updating the 1987 Statement, we do not
suggest that labeling will address all
hazards EPA identified in its proposed
rulemaking.
sradovich on DSK3GMQ082PROD with RULES
III. Federal Hazardous Substances Act
(FHSA) Labeling Requirements
The CPSC regulates hazardous
household substances under the FHSA,
15 U.S.C. 1261–1276. Section 2(p)(1) of
the FHSA, 15 U.S.C. 1261(p)(1), requires
that a hazardous substance bear certain
cautionary statements on its label in a
prominent and conspicuous manner so
that consumers can safely use and store
the product in and around the
household. A product is a ‘‘hazardous
substance’’ under the FHSA if the
substance or a mixture of substances is
toxic, corrosive, an irritant, a strong
sensitizer, is flammable or combustible,
or generates pressure through
decomposition, heat, or other means,
and if the substance or mixture of
substances may cause substantial
personal injury or substantial illness
during customary or reasonably
foreseeable handling or use, including
reasonably foreseeable ingestion by
children.
The FHSA defines ‘‘toxic’’ as ‘‘any
substance . . . which has the capacity
to produce personal injury or illness to
man through ingestion, inhalation, or
absorption through any body surface.’’
15 U.S.C. 1261(g). The Commission has
issued a regulation at 16 CFR 1500.3(c),
which supplements the statutory
definition of ‘‘toxic’’ based on the
outcome of any of the approved test
methods described in CPSC’s animal
testing policy set forth at 16 CFR
1500.232. This definition also includes
chronic toxicity and states that a
substance is toxic if it presents a chronic
hazard, if it is a known or probable
human carcinogen, neurotoxin, or
developmental or reproductive toxicant.
Under the FHSA, an article that is
intended, or packaged in a form suitable
for household use and meets the
definition of ‘‘hazardous substance’’ is a
‘‘misbranded hazardous substance’’
unless its packaging or labeling warns of
the hazard in accordance with the
requirements of section 2(p). 15 U.S.C.
1261(p). Thus, cautionary statements are
required for household substances
meeting the definition of ‘‘hazardous
substance’’ under the FHSA, whether
the hazard is acute or chronic.
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
IV. Staff’s Review of Toxicity and
Incident Data
A. Acute Toxicity Data
CPSC staff reviewed relevant data to
evaluate the acute toxicity risk to
consumers from using DCM-containing
products in residential settings. Staff’s
petition briefing package provided
detailed information about staff’s
review. (https://www.cpsc.gov/s3fspublic/RCA%20-%20Petition
%20HP%2016-1%20Labeling%20of
%20Household%20Products
%20Containing%20Methylene
%20Chloride%20082316.pdf).
DCM is a highly volatile, colorless,
organic substance used as a solvent in
a variety of consumer and commercial
products, including paint strippers,
adhesives and adhesive removers, spray
paint, spray shoe polish, and cleaners.
DCM’s high volatility makes inhalation
its primary route of exposure.1 The
acute toxicity risks for consumers using
DCM-based products in residential
settings range from upper respiratory,
ocular and dermal irritation, to severe
effects, such as respiratory suppression,
loss of consciousness, and death.2 Both
consumer and worker deaths have been
attributed to scenarios where the
individuals were working alone in an
enclosed and/or poorly ventilated space
(e.g., bathrooms, basements, sheds)
without respiratory protection. The
toxic effects are from DCM as well as
carbon monoxide (CO), which is a
metabolite of DCM. Bystanders are also
at risk of acute health effects while in
the home when paint strippers and
similar DCM-based products are being
applied.3
The primary route of exposure for
DCM is inhalation; however, DCM can
readily be absorbed through dermal
(skin) contact as well. To protect against
skin absorption, butyl rubber or
polyvinyl alcohol gloves must be worn
because latex gloves will not protect
against skin absorption.4 DCM should
only be used in a well-ventilated area.
In 2013, CPSC staff developed a
pamphlet concerning paint strippers
which provides guidance to consumers
on ventilation practices when they use
1 ATSDR. 2000a. TOXICOLOGICAL PROFILE
FOR METHYLENE CHLORIDE. 3.13; CDC. 2012.
Fatal Exposure to Methylene Chloride Among
Bathtub Refinishers—United States, 2000–2011.
MMWR. 61:4; EPA. 2014. TSCA Work Plan
Chemical Risk Assessment Methylene Chloride:
Paint Stripping Use. EPA Document #740–R1–4003.
August 2014:279.
2 EPA. 2009. INTERIM ACUTE EXPOSURE
GUIDELINE LEVELS (AEGLs) for METHYLENE
CHLORIDE. Interim 1: 12/2008:110.
3 EPA, 2014.
4 CDC, 2012. CPSC. 1987b. Statement of Policy for
Methylene Chloride. FindLaw; IRIS, 2011.
PO 00000
Frm 00009
Fmt 4700
Sfmt 4700
12255
DCM-containing paint strippers. The
CPSC pamphlet recommends that paintstripping work be done professionally if
the work area has low-ventilation
conditions.5 The U.S. Department of
Labor’s Occupational Safety and Health
Administration (OSHA) indicates in its
hazard alerts that bathroom fans and/or
open windows do not provide adequate
ventilation when using these paint
strippers in an enclosed space, such as
a bathroom.6 Inhalation exposure to as
little as six ounces is sufficient to cause
death.7 While working with DCM,
consumers and workers must use
respiratory protective equipment, such
as tight-fitting, full-face, self-contained
supplied-air respirators or gas masks
with vapor canisters, to reduce
exposure.8 Because DCM vapors are
heavier than air, they can remain in the
work area and become very hazardous
to users. For example, if using a DCMcontaining paint stripper to renovate a
bathtub, inhalation exposure could
occur due to the vapors remaining in the
bathtub after application.9 This
exposure may lead to death if proper
precautions, such as protective
equipment and ventilation, are not
used.10 To obtain adequate ventilation,
use a qualified occupational health and
safety specialist to assist in designing
and installing local exhaust ventilation
to effectively control vapors to below
applicable personal exposure levels.
B. Incident Data
Staff searched CPSC databases for
information about incidents reported to
CPSC associated with DCM-based paint
strippers and other household products
containing DCM. Staff also searched the
Consumer Product Safety Risk
Management System (CPSRMS) and the
National Electronic Injury Surveillance
System (NEISS).
Between January 1, 2000 and
November 30, 2017, there were 30
incidents associated with household
products containing or likely containing
DCM reported to CPSC by December 5,
2017. The majority of the incidents (28)
were associated with paint strippers;
one incident was associated with an
unspecified solvent; and one incident
5 CPSC, 2013. What You Should Know About
Using Paint Strippers. 423.
6 OSHA, 2013. Hazard Alert. ‘‘Methylene
Chloride Hazards for Bathtub Refinishers’’; OSHA,
2016. FATAL Facts, Ho. 13–2016, ‘‘Lethal Exposure
to Methylene Chloride during Bathtub Refinishing.’’
7 OSHA, 2013.
8 OSHA DCM regulations, 29 CFR 1910.1052,
require employers to supply employees with
respirators, and require employees to use the
respirator when exposures are likely to exceed the
regulatory limits.
9 CDC, 2012.
10 ATSDR, 2000b; CDC, 2012; EPA, 2014.
E:\FR\FM\21MRR1.SGM
21MRR1
sradovich on DSK3GMQ082PROD with RULES
12256
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
was associated with a sealant. The
incident reports mentioned fumes,
inhalations, skin and lung irritation,
leaking, and spilling. Based on
information provided by consumers, 17
incidents were associated with DCMbased household products (the incidents
either mentioned DCM or provided the
product SKU# that allowed CPSC staff
to identify a DCM-based product).
Thirteen incident reports named paint
strippers containing DCM.11 CPSC staff
determined that these incidents are
likely associated with DCM-based paint
strippers. Among the 30 reported
incidents, there were 6 fatalities, 1
hospital admission, 1 emergency
department visit, 15 injuries/adverse
health problems, 4 non-injury incidents,
and 3 incidents without enough
information to determine whether an
injury occurred.
CPSC staff is aware of six deaths
involving DCM-based products 12 that
occurred between January 1, 2000, and
November 30, 2017. The victims were
males between 45 and 80 years old. In
most of the cases (5 deaths), CPSC staff
was not able determine whether the
incidents were associated with a
consumer or a worker. These fatal
incidents are described in more detail in
the petition briefing package. The
Commission has since learned of an
incident that occurred in October 2017,
in Charleston, SC, involving a paint
stripper, which resulted in death from
acute DCM and methanol toxicity. This
case is still under investigation to
determine whether it is a consumer or
worker incident.
In 2002, a 64-year-old male fell into
a tank of paint stripper at work. The
paint stripper contained DCM. The
cause of death was recorded as a cardiac
arrest and respiratory toxicity. Although
this case is a work-related incident, and
therefore, not within CPSC’s
jurisdiction, the case, nonetheless,
indicates the potential hazard of the
product. Another incident that occurred
in 2002 involved a 52-year-old male. He
died as a consequence of inhaling fumes
from a DCM-based solvent in a
bathroom. In 2007, a 45-year-old male
died after inhaling paint remover fumes
during a bathroom renovation. The
cause of death was determined to be
asphyxia due to inhaling DCM. In 2013,
an 80-year-old male died after inhaling
DCM fumes while using a paint stripper
in a shed. Also reported in 2013, a 50year-old male died after inhaling DCM
11 California Department of Public Health, ‘‘Guide
to choosing paint stripping products: Safety
considerations’’ https://www.cdph.ca.gov/programs/
hesis/Documents/Paint-Removal-Methods.pdf.
12 These DCM-based products included four paint
removers, one unspecified solvent, and one sealer.
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
fumes while stripping an apartment’s
bathroom. In 2016, a 48-year-old male
was sealing bathroom shower tiles with
a DCM-based sealer in a bathroom. He
died as a consequence of asphyxiation
from exposure to toxic DCM fumes.
V. Labeling Paint Strippers Containing
Methylene Chloride
This section contains guidance on
minimum recommendations for how the
acute and chronic health risks of DCM
use could be conveyed in the Principal
Display Panel (PDP) and the back or
other panel to effectively inform
consumers and motivate their safe use
of paint stripping products containing
DCM.
Currently, there are few suitable
alternatives to DCM, and protective
measures, such as moving products
outdoors to apply the stripper can be
inconvenient. Providing warning
information does not prevent consumer
exposure to hazards, but instead, relies
upon persuading consumers to alter
their behavior in some way to avoid the
hazard. In addition, warnings research
demonstrates that even small
inconveniences to the consumer can
have a substantial negative effect on
behavioral compliance with a
warning.13 Therefore, it is imperative
that warning labels are formatted and
contain information so that they are
likely to be noticed, read, understood,
and heeded.
A. General Principles of Warning Labels
1. Format of Warning Label
Research has shown that warning
information is more effective when it is
conspicuous.14 Repetition with
variation and consistent reinforcement
can increase the effectiveness of
messages.15 Strategic use of
capitalization, bolding, underlining, and
other forms of highlighting information
can steer the consumer’s attention to the
most pertinent information by making it
stand out from the surrounding text.16
13 Ayres T.J., Gross M.M., Wood C.T., Horst D.P,
Beyer R.R., & Robinson J.N. (1989). What is a
Warning and When Will it Work? Proceedings of
the Human Factors Society Annual Meeting, 33.
426–430; Riley, D.M. (2006). Beliefs, Attitudes, and
Motivation. In M.S. Wogalter (Ed.), Handbook of
Warnings (pp. 289–300). Mahwah, NJ: Lawrence
Erlbaum Associates.
14 Wogalter, M.S., DeJoy, D., & Laughery, K.R.
(Eds.). (1999). Warnings and risk communication.
Philadelphia, PA: Taylor & Francis.
15 Food and Drug Administration. (2011).
Communicating risks and benefits: An evidencebased user’s guide (DHHS). B. Fischhoff, N.T.
Brewer & J.S.Downs (Eds.).
16 Wogalter, M.S., Conzola, V.C., & Smith-Jackson,
T.L. (2002). Research-based guidelines for warning
design and evaluation. Applied Ergonomics, 33,
219–230.
PO 00000
Frm 00010
Fmt 4700
Sfmt 4700
2. Order of Safety Information
Experts in the communication of
safety information agree that associated
hazards and symptoms should be
mentioned from most-to-least severe.17
Research indicates that many consumers
will only read as much of the safety
information as they think they have to
read and only if the rewards meet or
exceed the efforts.18 If lesser hazards
and symptoms of overexposure to DCM
precede more severe hazards and
symptoms on the label, then the
consumer might stop reading the label
before reaching the more severe hazards
and symptoms. Mentioning lethality of
vapor inhalation at the start raises the
likelihood that the consumer is
informed of the possibility of death. By
highlighting the pertinent information
and beginning with the risk of death, the
warning information is more apt to
prove to the consumer that the warning
contains useful information, and is,
thereby, more likely to be read in its
entirety. Furthermore, the Commission
believes that if lesser symptoms of
overexposure were to precede more
severe symptoms on the warning labels,
then consumers may expect lesser
symptoms to happen before more severe
symptoms present, which may not be
the case. For example, if consumers read
that DCM inhalation can cause nausea
and dizziness, before reading that DCM
can cause death, consumers may infer,
incorrectly, that they will not be killed
by the product without first exhibiting
nausea or dizziness. Presenting effects
of overexposure from most to least
severe, along with stating that
symptoms may not be noticeable, helps
to dispel the false expectation that the
way the consumer is using the DCMcontaining paint stripper is safe, or that
the consumer can use it in an unsafe
manner, until s/he notices lesser
symptoms of overexposure.
3. Warning Label Comprehension
It is important for warning
information not only to be noticed and
read, but also understood. Warnings
should be free of ambiguity to better
ensure that the intended message is
received and not easily
misinterpreted.19 For example, the
phrase ‘‘adequate ventilation’’ is
ambiguous and can encourage
inappropriate methods of
circumvention; from ‘‘adequate
ventilation’’ the consumer may infer
that any addition of ventilation to the
application area, such as opening a
window, will be sufficient to make the
17 Wogalter
et al., 1999.
2009; Schriver, 1997.
19 Wogalter et al., 1999.
18 Robinson,
E:\FR\FM\21MRR1.SGM
21MRR1
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
sradovich on DSK3GMQ082PROD with RULES
product safe for indoor use. Such an
inference can lead to overexposure to
DCM-containing vapors, potentially
resulting in death. Similarly, unclear
wording, such as, ‘‘use in enclosed areas
may kill you,’’ carries the risk of being
misread as simply, ‘‘use in enclosed
areas,’’ because the word ‘‘use’’ in this
context can be read as a verb, such as
‘‘use this product,’’ rather than read as
a noun, such as ‘‘use of this product,’’
and because the consumer may stop
reading the statement before reaching
‘‘may kill you.’’
To increase the likelihood of
consumers heeding a warning despite
inconveniences imposed by necessary
precautions, the phrasing of warning
information should be vivid and
relatable.20 The Commission
recommends using the phrase ‘‘can kill
you,’’ as opposed to wording like: ‘‘may
cause death.’’ These phrases have the
same denotation; however, the impact
on the reader can be different in
meaningful ways. The Commission
believes lethality is more salient with
the statement ‘‘can kill you’’ because it
is more personalized, directing the
hazard toward the user, rather than as
a possibility for users, in general.
Evidence suggests that emotional
communications, especially those that
are fear-based, can be used to increase
risk perceptions and change behaviors;
and stronger fear-arousing conditions
may lead to greater message
acceptance.21
4. Effect of Consumer Experience With
Product
Warning information can be formatted
in a way that is noticeable, more likely
to be read, understood, and motivating,
and yet remain unheeded. Research
indicates that consumers who are
familiar or experienced with a product
are less likely to search for and comply
with warnings.22 Paint strippers
containing DCM have been around for
decades, and incident data show that
these products are sometimes applied
indoors, such as in bathrooms,
basements, and closets. The
Commission believes that it is
foreseeable that some consumers will
continue to use these products indoors,
despite warnings against using them in
enclosed areas because of past incidentfree experience with indoor use of
stripping products containing DCM.
Therefore, the Commission suggests
20 Murray-Johnson, L., & Witte, K. (2003). Looking
toward the future: Health message design strategies.
In T.L. Thompson, A. Dorsey, K.I. Miller, & R.
Parrot (Eds.), Handbook of health communication
(pp.473–495). New York City, NY: Routledge.
21 Food and Drug Administration, 2011.
22 Wogalter et al., 1999.
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
including precautions for indoor use as
well. However, because providing
precautions for indoor use may mislead
some consumers to believe it is safe to
use DCM-based products indoors, the
Commission recommends that the
language and format of the safety
information clarify that use in enclosed
areas is dangerous, even with
precautions, and should be avoided, if
possible. The examples provided
specify that indoor use is dangerous,
and they employ repetition and
capitalization to reinforce the point that
paint-stripping products containing
DCM should be used outdoors in open
air areas.
B. Principal Display Panel (PDP)
Minimum Labeling Recommendations
This section provides
recommendations for labeling paint
stripping products that contain
methylene chloride. The following
minimum labeling recommendations for
the PDP meet the requirements of the
FHSA. There are wide variations in the
concentrations of methylene chloride in
paint strippers. The precise labeling
used may vary based on DCM
concentration, anticipated duration of
exposure, and other associated hazards.
The labels for all products subject to
the FHSA are expected to comply with
the requirements for prominence,
placement, and conspicuousness of
labeling required by section 2(p)(1) of
the FHSA. The FHSA provides that
required labeling statements may be
placed on the PDP, or front panel, on
the immediate container, and, if
appropriate, on any other container or
wrapper. The appropriate signal word
(i.e., ‘‘DANGER,’’ ‘‘WARNING,’’ or
‘‘CAUTION) and the statement of
principal hazard[s] are required to be on
the PDP. The other items of required
labeling may be placed on some other
display panel on the container,
provided that the front panel contains
the statement: ‘‘Read carefully other
cautions on the [other display] panel,’’
or its practical equivalent.
• The Commission recommends
‘‘WARNING’’ as the signal word for the
label. Given cases of lethal exposure to
DCM in household products, the
Commission considered the signal word
‘‘DANGER’’; however, the current DCM
toxicity data do not meet the FHSA
definition of ‘‘highly toxic,’’ which is
required for use of the the signal word
‘‘DANGER.’’
• When providing affirmative
statements of all principal hazards, the
Commission recommends stating:
‘‘INHALATION OF VAPOR VERY
HARMFUL,’’ followed by: ‘‘VAPOR
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
12257
CAN KILL YOU IN ENCLOSED
AREAS.’’
Example From 1987 Statement of
Cautionary Labeling To Be Included on
the PDP 23
In 1987, the Steering Committee for
Methylene Chloride, a group of industry
and consumer-interest representatives
working with Commission staff,
recommended the following labeling for
the PDP for products, such as some
paint strippers that contain high
percentages of DCM:
CAUTION: Vapor Harmful, Read Other
Cautions and HEALTH HAZARD
INFORMATION on Back Panel
In the 1987 Statement, the
Commission presented this labeling for
the PDP as an example that would meet
or exceed the minimum requirements of
the FHSA.
Updated Example of Cautionary
Labeling
In recognition of updated data on
acute health risks of DCM use, the
Commission recommends replacing the
1987 example of cautionary labeling to
be included on the PDP with the
information and format below:
WARNING: INHALATION OF VAPOR VERY
HARMFUL VAPOR CAN KILL YOU IN
ENCLOSED AREAS EYE AND SKIN
IRRITANT. Read All Cautions on Back/
Side Panel.
The format in the updated PDP
example uses capital letters, repetition,
and personalized language to draw
attention to the most severe hazard:
Death from inhalation of vapor in
enclosed areas. The repetition of
‘‘vapor’’ between the first and second
lines aids in communicating the source
and medium by which the hazard
presents itself. The inclusion of ‘‘vapor
very harmful’’ satisfies the declaration
of both the acute and the chronic
hazard. When a chronic hazard exists,
the additional risk of cancer should be
included on the back or other panel, as
appropriate under the FHSA. The last
line directs the consumer to the back or
other panel, which provides detailed
precautionary information.
C. Back or Other Panel
1. Back or Other Panel Minimum
Labeling Recommendations
The Commission recommends the
following information and formatting
for the back or other panel of paint
stripping products containing DCM.
23 Given the previously limited data on the acute
toxicity of overexposure to DCM, the Commission
believed this labeling to meet, and in certain
respects exceed, the minimum requirements of
section 2(p)(1) of the FHSA.
E:\FR\FM\21MRR1.SGM
21MRR1
12258
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
sradovich on DSK3GMQ082PROD with RULES
These recommendations cover both
acute and chronic hazards. Again, the
statements may vary based on the
concentration of DCM, anticipated
duration of exposure, and other
associated hazards.
• The Commission recommends use
of ‘‘WARNING’’ as the signal word for
the label.
• The Commission recommends
beginning the precautionary information
by stating, in all capital letters, the
lethality of vapor inhalation and not to
use the product in enclosed areas.
• The FHSA requires disclosure of all
principal hazards. The Commission
recommends disclosing the acute and
chronic hazards from most-to-least
severe. Similarly, when symptoms are
mentioned, the Commission
recommends it would be most effective
to state symptoms from most-to-least
severe.
• Because overexposure to DCM may
be sudden and can inhibit the user’s
capability to notice and react to the
effects, the Commission recommends
indicating in all capital letters that
symptoms may not be noticeable.
• The Commission recommends
separating precautionary statements by
bullet points, if paragraph formatting is
used, to aid visual distinction between
precautions.24
• The Commission believes it will be
helpful to provide specific examples of
spaces in which the product should not
be used, beginning with bathrooms,
basements, and closets because these
locations are particularly dangerous and
have been cited in incident data.
• When indicating precautions to be
taken, the Commission recommends
stating in all capital letters that the
product should be used outdoors in an
open-air area.
• The Commission recommends
including precautionary information for
indoor use, accompanied by language
stating that indoor use is dangerous
even when precautions are taken.
• The Commission recommends
prohibiting foreseeable inappropriate
actions, such as use of a dust mask to
provide protection against vapors.25
• When providing instructions for
first-aid, the Commission recommends
listing in order of the likelihood of
occurrence, the types of exposures and
placing each exposure route on a
separate line to aid DCM users in an
urgent situation.
24 See the ‘‘Recommended Language Approved by
Ad Hoc Task Group, Revision C’’ document dated
November 10, 2017, published in the ‘‘Committee
Documents’’ section of the Committee F15 ASTM
website.
25 A dust mask does not provide effective
protection against overexposure to vapors
containing DCM.
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
2. Example of Updated Safety
Information To Be Included on the Back
or Other Panel
In recognition of updated data on
acute health risks of DCM use, the
Commission recommends replacing the
1987 example of labeling to be included
on the back or other panel, with the
information and format below:
WARNING Contains Methylene Chloride.
INHALATION OF VAPOR CAN KILL YOU.
DO NOT USE IN ENCLOSED AREAS, such
as bathrooms, basements, or closets.
SYMPTOMS MAY NOT BE NOTICEABLE.
D Avoid contact with eyes or skin, as severe
irritation can occur. D Methylene Chloride
may cause cancer. D The risk to your health
depends on the level and duration of
exposure. D Keep out of the reach of children.
SAFETY DIRECTIONS: D USE OUTDOORS
IN AN OPEN AIR AREA. It is dangerous to
use this product indoors. D If you must use
indoors, cross-ventilate work area by opening
all windows and doors and circulating fresh
air through the work area to reduce vapor
accumulation. D Always wear chemicalsplash goggles and chemical-resistant gloves
when handling this product. D A dust mask
does not provide protection against the
vapors.
FIRST–AID:
• INHALATION: First move person to
fresh air. If not breathing, give artificial
respiration. Call 911, or poison control
center, or emergency room.
• EYE EXPOSURE: Immediately flush
affected eye(s) with water. Call 911, or poison
control center, or emergency room, as soon
as possible.
• SKIN EXPOSURE: Immediately wash
skin with soap and water. Avoid spreading
material on unaffected skin. Remove
contaminated clothing and shoes, and
thoroughly clean before reuse. Contact
medical professional for advice.
• IF SWALLOWED: IMMEDIATELY call
911, or poison control center, or emergency
room. Do NOT induce vomiting, unless
directed to do so by medical personnel.
Never give anything by mouth to an
unconscious person.
In the preceding updated back or
other panel example, the most
important safety information is
capitalized to attract the consumer’s
attention; i.e., if the consumer only
reads the capitalized words, his/her
focus is drawn to the following
information: Inhaling the vapor can be
deadly; the product should not be used
in enclosed areas; symptoms of
overexposure may go unnoticed; and the
product should be used outdoors. Bullet
points are used to aid visual distinctions
among precautions. The presentation of
the hazards from most-to-least severe,
coupled with the statement that
symptoms may go unnoticed, helps to
dismiss the false expectation that the
consumer can wait for noticeable
symptoms before taking appropriate
precautions or escaping from a
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
potentially lethal-use scenario. Steps for
inhibiting vapor accumulation indoors
are included in the back or other panel,
subsequent to reiteration that household
products containing DCM should be
used outdoors and that indoor use is
dangerous. The instructions for first-aid
are adapted from OSHA’s Chemical
Database.26 The instructions are listed
in order of the likelihood of exposure
route per incident data. Types of
exposure are capitalized and addressed
on separate lines for ease of access to
the information in a hurried state. The
company’s toll-free number is provided
for consumers to seek more information
about appropriate use and first-aid.
VI. Implementation of This Guidance
In this update of the 1987 Statement,
the Commission provides guidance to
industry on determining the appropriate
cautionary labeling for paint-stripping
products that contain DCM. This
guidance also provides examples of
statements to convey the hazards
associated with the product. This
guidance does not set forth language for
particular products; nor does it specify
placement of this language. However,
this document does provide guidance
on the factors to consider in developing
the cautionary statements, and it gives
examples that satisfy the FHSA. The
level of hazard varies, based on the
formulation of the product, the
concentration of DCM, and the
customary and reasonably foreseeable
use of the product. If a paint stripper
containing methylene chloride does not
appear to be labeled appropriately,
Commission staff will provide guidance
to firms and assist firms with labeling
their products.
Under the FHSA, manufacturers are
responsible for determining whether
their methylene chloride-containing
products meet the definition of a
‘‘hazardous substance,’’ and bear the
appropriate cautionary statements. This
determination is based on the
concentration of methylene chloride,
the use of the product, and whether the
product presents a significant exposure
to methylene chloride vapor with
customary and reasonably foreseeable
use. This update of the 1987 Statement
provides guidance to manufacturers
who must determine the appropriate
labeling for their paint stripper products
that contain methylene chloride. In any
enforcement action, Commission staff
would consider on a case-by-case basis
26 OSHA Occupational Chemical Database for
Methylene Chloride: https://www.osha.gov/
chemicaldata/chemResult.html?recNo=572,
accessed on December 8, 2017.
E:\FR\FM\21MRR1.SGM
21MRR1
Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Rules and Regulations
whether the product’s labeling meets
the requirements of the FHSA.
VII. Effect on State and Local Laws
In general, the preemption language
in section 18(b)(1)(A) of the FHSA
provides that if a hazardous substance
or its packaging is subject to a
cautionary labeling requirement under
the FHSA designed to protect against a
risk of illness or injury associated with
the substance, no State or political
subdivision of a State may establish or
continue in effect a cautionary labeling
requirement applicable to a hazardous
substance or packaging that is designed
to protect against the same risk of illness
or injury, unless the cautionary labeling
requirement is identical to the labeling
requirement under the FHSA. 15 U.S.C.
1261n. As mentioned, this document
provides guidance to industry. This
guidance does not have binding legal
force, does not constitute a rule, and
thus, does not have preemptive effect.
However, the underlying duty to label a
hazardous household product arises
from the FHSA. This underlying
statutory obligation preempts state and
local non-identical cautionary labeling
requirements that are designed to
protect against the same risk of injury or
illness.
Alberta E. Mills,
Secretary, Consumer Product Safety
Commission.
[FR Doc. 2018–05580 Filed 3–20–18; 8:45 am]
BILLING CODE 6355–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
addresses combination product
postmarketing safety reporting. This
guidance is immediately in effect, but it
remains subject to comment in
accordance with the Agency’s good
guidance practices.
DATES: The announcement of the
guidance is published in the Federal
Register on March 21, 2018.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
21 CFR Part 4
Written/Paper Submissions
[Docket No. FDA–2008–N–0424]
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2008–N–0424 for ‘‘Compliance Policy
for Combination Product Postmarketing
Safety Reporting.’’ Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Immediately in Effect Guidance for
Industry; Compliance Policy for
Combination Product Postmarketing
Safety Reporting; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of an
immediately in effect guidance for
industry entitled ‘‘Compliance Policy
for Combination Product Postmarketing
Safety Reporting.’’ This guidance
describes FDA’s compliance policy for
combination product applicants and
constituent part applicants and
activities under FDA regulations that
sradovich on DSK3GMQ082PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:29 Mar 20, 2018
Jkt 244001
PO 00000
Frm 00013
Fmt 4700
Sfmt 4700
12259
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Office of
Combination Products, Food and Drug
Administration, Bldg. 32, Rm. 5129,
10903 New Hampshire Ave., Silver
Spring, MD 20993. Send one selfaddressed adhesive label to assist that
office in processing your requests. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance
document.
FOR FURTHER INFORMATION CONTACT:
Melissa Burns, Office of Combination
E:\FR\FM\21MRR1.SGM
21MRR1
Agencies
[Federal Register Volume 83, Number 55 (Wednesday, March 21, 2018)]
[Rules and Regulations]
[Pages 12254-12259]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05580]
=======================================================================
-----------------------------------------------------------------------
CONSUMER PRODUCT SAFETY COMMISSION
16 CFR Chapter II
[Docket No. CPSC-2016-2019]
Labeling of Certain Household Products Containing Methylene
Chloride; Supplemental Guidance
AGENCY: Consumer Product Safety Commission.
ACTION: Guidance.
-----------------------------------------------------------------------
SUMMARY: The Halogenated Solvents Industry Alliance petitioned the
Consumer Product Safety Commission to amend its 1987 policy statement
regarding the labeling of certain products containing methylene
chloride to address acute hazards from inhaling methylene chloride
vapors in addition to the chronic hazards addressed in the policy
statement. In this document, the Commission updates the 1987 policy
statement to provide guidance regarding the labeling to warn of acute
hazards associated with paint strippers containing methylene chloride.
DATES: This guidance document becomes applicable on March 21, 2018.
FOR FURTHER INFORMATION CONTACT: Carol Afflerbach, Office of Compliance
and Field Operations, U.S. Consumer Product Safety Commission; 4330
East-West Highway, Bethesda, MD 20814; email: [email protected];
telephone: (301) 504-7529.
SUPPLEMENTARY INFORMATION:
I. Background
In 1987, the U.S. Consumer Product Safety Commission (CPSC or
Commission) issued a Statement of Interpretation and Enforcement Policy
regarding the labeling of certain household products containing
methylene chloride (1987 Statement), 52 FR 34698 (Sept. 14, 1987). The
1987 Statement noted that the Commission considers certain household
products containing methylene chloride (DCM) to be ``hazardous
substances'' under the FHSA and may pose a risk of carcinogenicity. The
1987 Statement identified several categories of products that contained
methylene chloride that could expose consumers to significant amounts
of methylene chloride vapor, and were thus hazardous substances. Paint
strippers were one of these product categories. The 1987 Statement
advised manufacturers of the FHSA's labeling requirements and provided
guidance for labeling those products, including paint strippers, to
warn of the cancer risk from inhaling methylene chloride vapor.
On July 7, 2016, the Halogenated Solvents Industry Alliance (HSIA
or petitioner) petitioned the CPSC to amend its 1987 Statement to
recognize the acute hazard posed by using household products containing
DCM in enclosed spaces with inadequate ventilation. The petitioner
stated that using household products containing DCM in bathrooms, or
other enclosed spaces, with inadequate ventilation can be dangerous.
When consumers use methylene chloride to strip coatings from bathtubs,
they often spray or pour a bathtub stripping product into the basin of
the bathtub and then brush the product onto the tub surface. Many of
these stripping products contain substantial amounts of methylene
chloride. According to the petitioner, methylene chloride is a volatile
organic compound that will evaporate quickly when sprayed, brushed, or
poured, so that its vapor can quickly build up in small spaces. The
petitioner stated that DCM has a high vapor pressure, which causes
vapors to collect in the bottom of a bathtub and in a consumer's
breathing zone when working in a bathtub. This situation can create
dangerously high concentrations of DCM, and in some cases, replace the
breathable air. The petitioner asked the Commission to expand the
cautionary labeling guidance so that it also warns of the threat of
asphyxiation if DCM-based paint strippers are used in an enclosed
space.
CPSC staff prepared a briefing package in response to the petition
and submitted the package to the Commission on May 26, 2017. On June 2,
2017, the Commission voted unanimously (5-0) to grant the petition (HP
16-1) and directed CPSC staff to draft a policy statement that
addresses labeling for acute hazards from inhaling methylene chloride
vapors from paint strippers.
II. EPA Rulemaking
The EPA has initiated rulemaking under section 6(a) of the Toxic
Substances Control Act (TSCA) to address risks posed by DCM when used
in paint and coating removal products. Specifically, EPA has issued a
proposed rule that provides an assessment of the health hazards posed
by DCM and that proposes to determine that DCM in these products
presents an unreasonable risk of injury to health. Based on this
determination, and after considering regulatory alternatives, EPA
proposed to prohibit the manufacture (including import), processing,
and distribution in commerce of DCM for all consumer and most
commercial paint removal products, and to prohibit commercial use. 82
FR 7464 (Jan. 19, 2017). EPA's rulemaking would address both consumer
and worker exposures to DCM used for paint and coating removal. While
developing its rulemaking, EPA consulted with CPSC staff. Under EPA's
rulemaking (if finalized as proposed), paint and coating removal
products containing DCM would no longer be on the market for consumers
or commercial workers, except in limited circumstances. To date, EPA
has not finalized its rulemaking. Accordingly,
[[Page 12255]]
the Commission believes that updating CPSC's 1987 Statement would
provide more immediate guidance and clarity to industry and consumers
regarding the acute hazards associated with using DCM-containing paint
strippers while those products remain on the market. By updating the
1987 Statement, we do not suggest that labeling will address all
hazards EPA identified in its proposed rulemaking.
III. Federal Hazardous Substances Act (FHSA) Labeling Requirements
The CPSC regulates hazardous household substances under the FHSA,
15 U.S.C. 1261-1276. Section 2(p)(1) of the FHSA, 15 U.S.C. 1261(p)(1),
requires that a hazardous substance bear certain cautionary statements
on its label in a prominent and conspicuous manner so that consumers
can safely use and store the product in and around the household. A
product is a ``hazardous substance'' under the FHSA if the substance or
a mixture of substances is toxic, corrosive, an irritant, a strong
sensitizer, is flammable or combustible, or generates pressure through
decomposition, heat, or other means, and if the substance or mixture of
substances may cause substantial personal injury or substantial illness
during customary or reasonably foreseeable handling or use, including
reasonably foreseeable ingestion by children.
The FHSA defines ``toxic'' as ``any substance . . . which has the
capacity to produce personal injury or illness to man through
ingestion, inhalation, or absorption through any body surface.'' 15
U.S.C. 1261(g). The Commission has issued a regulation at 16 CFR
1500.3(c), which supplements the statutory definition of ``toxic''
based on the outcome of any of the approved test methods described in
CPSC's animal testing policy set forth at 16 CFR 1500.232. This
definition also includes chronic toxicity and states that a substance
is toxic if it presents a chronic hazard, if it is a known or probable
human carcinogen, neurotoxin, or developmental or reproductive
toxicant.
Under the FHSA, an article that is intended, or packaged in a form
suitable for household use and meets the definition of ``hazardous
substance'' is a ``misbranded hazardous substance'' unless its
packaging or labeling warns of the hazard in accordance with the
requirements of section 2(p). 15 U.S.C. 1261(p). Thus, cautionary
statements are required for household substances meeting the definition
of ``hazardous substance'' under the FHSA, whether the hazard is acute
or chronic.
IV. Staff's Review of Toxicity and Incident Data
A. Acute Toxicity Data
CPSC staff reviewed relevant data to evaluate the acute toxicity
risk to consumers from using DCM-containing products in residential
settings. Staff's petition briefing package provided detailed
information about staff's review. (https://www.cpsc.gov/s3fs-public/RCA%20-%20Petition%20HP%2016-1%20Labeling%20of%20Household%20Products%20Containing%20Methylene%20Chloride%20082316.pdf).
DCM is a highly volatile, colorless, organic substance used as a
solvent in a variety of consumer and commercial products, including
paint strippers, adhesives and adhesive removers, spray paint, spray
shoe polish, and cleaners. DCM's high volatility makes inhalation its
primary route of exposure.\1\ The acute toxicity risks for consumers
using DCM-based products in residential settings range from upper
respiratory, ocular and dermal irritation, to severe effects, such as
respiratory suppression, loss of consciousness, and death.\2\ Both
consumer and worker deaths have been attributed to scenarios where the
individuals were working alone in an enclosed and/or poorly ventilated
space (e.g., bathrooms, basements, sheds) without respiratory
protection. The toxic effects are from DCM as well as carbon monoxide
(CO), which is a metabolite of DCM. Bystanders are also at risk of
acute health effects while in the home when paint strippers and similar
DCM-based products are being applied.\3\
---------------------------------------------------------------------------
\1\ ATSDR. 2000a. TOXICOLOGICAL PROFILE FOR METHYLENE CHLORIDE.
3.13; CDC. 2012. Fatal Exposure to Methylene Chloride Among Bathtub
Refinishers--United States, 2000-2011. MMWR. 61:4; EPA. 2014. TSCA
Work Plan Chemical Risk Assessment Methylene Chloride: Paint
Stripping Use. EPA Document #740-R1-4003. August 2014:279.
\2\ EPA. 2009. INTERIM ACUTE EXPOSURE GUIDELINE LEVELS (AEGLs)
for METHYLENE CHLORIDE. Interim 1: 12/2008:110.
\3\ EPA, 2014.
---------------------------------------------------------------------------
The primary route of exposure for DCM is inhalation; however, DCM
can readily be absorbed through dermal (skin) contact as well. To
protect against skin absorption, butyl rubber or polyvinyl alcohol
gloves must be worn because latex gloves will not protect against skin
absorption.\4\ DCM should only be used in a well-ventilated area. In
2013, CPSC staff developed a pamphlet concerning paint strippers which
provides guidance to consumers on ventilation practices when they use
DCM-containing paint strippers. The CPSC pamphlet recommends that
paint-stripping work be done professionally if the work area has low-
ventilation conditions.\5\ The U.S. Department of Labor's Occupational
Safety and Health Administration (OSHA) indicates in its hazard alerts
that bathroom fans and/or open windows do not provide adequate
ventilation when using these paint strippers in an enclosed space, such
as a bathroom.\6\ Inhalation exposure to as little as six ounces is
sufficient to cause death.\7\ While working with DCM, consumers and
workers must use respiratory protective equipment, such as tight-
fitting, full-face, self-contained supplied-air respirators or gas
masks with vapor canisters, to reduce exposure.\8\ Because DCM vapors
are heavier than air, they can remain in the work area and become very
hazardous to users. For example, if using a DCM-containing paint
stripper to renovate a bathtub, inhalation exposure could occur due to
the vapors remaining in the bathtub after application.\9\ This exposure
may lead to death if proper precautions, such as protective equipment
and ventilation, are not used.\10\ To obtain adequate ventilation, use
a qualified occupational health and safety specialist to assist in
designing and installing local exhaust ventilation to effectively
control vapors to below applicable personal exposure levels.
---------------------------------------------------------------------------
\4\ CDC, 2012. CPSC. 1987b. Statement of Policy for Methylene
Chloride. FindLaw; IRIS, 2011.
\5\ CPSC, 2013. What You Should Know About Using Paint
Strippers. 423.
\6\ OSHA, 2013. Hazard Alert. ``Methylene Chloride Hazards for
Bathtub Refinishers''; OSHA, 2016. FATAL Facts, Ho. 13-2016,
``Lethal Exposure to Methylene Chloride during Bathtub
Refinishing.''
\7\ OSHA, 2013.
\8\ OSHA DCM regulations, 29 CFR 1910.1052, require employers to
supply employees with respirators, and require employees to use the
respirator when exposures are likely to exceed the regulatory
limits.
\9\ CDC, 2012.
\10\ ATSDR, 2000b; CDC, 2012; EPA, 2014.
---------------------------------------------------------------------------
B. Incident Data
Staff searched CPSC databases for information about incidents
reported to CPSC associated with DCM-based paint strippers and other
household products containing DCM. Staff also searched the Consumer
Product Safety Risk Management System (CPSRMS) and the National
Electronic Injury Surveillance System (NEISS).
Between January 1, 2000 and November 30, 2017, there were 30
incidents associated with household products containing or likely
containing DCM reported to CPSC by December 5, 2017. The majority of
the incidents (28) were associated with paint strippers; one incident
was associated with an unspecified solvent; and one incident
[[Page 12256]]
was associated with a sealant. The incident reports mentioned fumes,
inhalations, skin and lung irritation, leaking, and spilling. Based on
information provided by consumers, 17 incidents were associated with
DCM-based household products (the incidents either mentioned DCM or
provided the product SKU# that allowed CPSC staff to identify a DCM-
based product). Thirteen incident reports named paint strippers
containing DCM.\11\ CPSC staff determined that these incidents are
likely associated with DCM-based paint strippers. Among the 30 reported
incidents, there were 6 fatalities, 1 hospital admission, 1 emergency
department visit, 15 injuries/adverse health problems, 4 non-injury
incidents, and 3 incidents without enough information to determine
whether an injury occurred.
---------------------------------------------------------------------------
\11\ California Department of Public Health, ``Guide to choosing
paint stripping products: Safety considerations'' https://www.cdph.ca.gov/programs/hesis/Documents/Paint-Removal-Methods.pdf.
---------------------------------------------------------------------------
CPSC staff is aware of six deaths involving DCM-based products \12\
that occurred between January 1, 2000, and November 30, 2017. The
victims were males between 45 and 80 years old. In most of the cases (5
deaths), CPSC staff was not able determine whether the incidents were
associated with a consumer or a worker. These fatal incidents are
described in more detail in the petition briefing package. The
Commission has since learned of an incident that occurred in October
2017, in Charleston, SC, involving a paint stripper, which resulted in
death from acute DCM and methanol toxicity. This case is still under
investigation to determine whether it is a consumer or worker incident.
---------------------------------------------------------------------------
\12\ These DCM-based products included four paint removers, one
unspecified solvent, and one sealer.
---------------------------------------------------------------------------
In 2002, a 64-year-old male fell into a tank of paint stripper at
work. The paint stripper contained DCM. The cause of death was recorded
as a cardiac arrest and respiratory toxicity. Although this case is a
work-related incident, and therefore, not within CPSC's jurisdiction,
the case, nonetheless, indicates the potential hazard of the product.
Another incident that occurred in 2002 involved a 52-year-old male. He
died as a consequence of inhaling fumes from a DCM-based solvent in a
bathroom. In 2007, a 45-year-old male died after inhaling paint remover
fumes during a bathroom renovation. The cause of death was determined
to be asphyxia due to inhaling DCM. In 2013, an 80-year-old male died
after inhaling DCM fumes while using a paint stripper in a shed. Also
reported in 2013, a 50-year-old male died after inhaling DCM fumes
while stripping an apartment's bathroom. In 2016, a 48-year-old male
was sealing bathroom shower tiles with a DCM-based sealer in a
bathroom. He died as a consequence of asphyxiation from exposure to
toxic DCM fumes.
V. Labeling Paint Strippers Containing Methylene Chloride
This section contains guidance on minimum recommendations for how
the acute and chronic health risks of DCM use could be conveyed in the
Principal Display Panel (PDP) and the back or other panel to
effectively inform consumers and motivate their safe use of paint
stripping products containing DCM.
Currently, there are few suitable alternatives to DCM, and
protective measures, such as moving products outdoors to apply the
stripper can be inconvenient. Providing warning information does not
prevent consumer exposure to hazards, but instead, relies upon
persuading consumers to alter their behavior in some way to avoid the
hazard. In addition, warnings research demonstrates that even small
inconveniences to the consumer can have a substantial negative effect
on behavioral compliance with a warning.\13\ Therefore, it is
imperative that warning labels are formatted and contain information so
that they are likely to be noticed, read, understood, and heeded.
---------------------------------------------------------------------------
\13\ Ayres T.J., Gross M.M., Wood C.T., Horst D.P, Beyer R.R., &
Robinson J.N. (1989). What is a Warning and When Will it Work?
Proceedings of the Human Factors Society Annual Meeting, 33. 426-
430; Riley, D.M. (2006). Beliefs, Attitudes, and Motivation. In M.S.
Wogalter (Ed.), Handbook of Warnings (pp. 289-300). Mahwah, NJ:
Lawrence Erlbaum Associates.
---------------------------------------------------------------------------
A. General Principles of Warning Labels
1. Format of Warning Label
Research has shown that warning information is more effective when
it is conspicuous.\14\ Repetition with variation and consistent
reinforcement can increase the effectiveness of messages.\15\ Strategic
use of capitalization, bolding, underlining, and other forms of
highlighting information can steer the consumer's attention to the most
pertinent information by making it stand out from the surrounding
text.\16\
---------------------------------------------------------------------------
\14\ Wogalter, M.S., DeJoy, D., & Laughery, K.R. (Eds.). (1999).
Warnings and risk communication. Philadelphia, PA: Taylor & Francis.
\15\ Food and Drug Administration. (2011). Communicating risks
and benefits: An evidence-based user's guide (DHHS). B. Fischhoff,
N.T. Brewer & J.S.Downs (Eds.).
\16\ Wogalter, M.S., Conzola, V.C., & Smith-Jackson, T.L.
(2002). Research-based guidelines for warning design and evaluation.
Applied Ergonomics, 33, 219-230.
---------------------------------------------------------------------------
2. Order of Safety Information
Experts in the communication of safety information agree that
associated hazards and symptoms should be mentioned from most-to-least
severe.\17\ Research indicates that many consumers will only read as
much of the safety information as they think they have to read and only
if the rewards meet or exceed the efforts.\18\ If lesser hazards and
symptoms of overexposure to DCM precede more severe hazards and
symptoms on the label, then the consumer might stop reading the label
before reaching the more severe hazards and symptoms. Mentioning
lethality of vapor inhalation at the start raises the likelihood that
the consumer is informed of the possibility of death. By highlighting
the pertinent information and beginning with the risk of death, the
warning information is more apt to prove to the consumer that the
warning contains useful information, and is, thereby, more likely to be
read in its entirety. Furthermore, the Commission believes that if
lesser symptoms of overexposure were to precede more severe symptoms on
the warning labels, then consumers may expect lesser symptoms to happen
before more severe symptoms present, which may not be the case. For
example, if consumers read that DCM inhalation can cause nausea and
dizziness, before reading that DCM can cause death, consumers may
infer, incorrectly, that they will not be killed by the product without
first exhibiting nausea or dizziness. Presenting effects of
overexposure from most to least severe, along with stating that
symptoms may not be noticeable, helps to dispel the false expectation
that the way the consumer is using the DCM-containing paint stripper is
safe, or that the consumer can use it in an unsafe manner, until s/he
notices lesser symptoms of overexposure.
---------------------------------------------------------------------------
\17\ Wogalter et al., 1999.
\18\ Robinson, 2009; Schriver, 1997.
---------------------------------------------------------------------------
3. Warning Label Comprehension
It is important for warning information not only to be noticed and
read, but also understood. Warnings should be free of ambiguity to
better ensure that the intended message is received and not easily
misinterpreted.\19\ For example, the phrase ``adequate ventilation'' is
ambiguous and can encourage inappropriate methods of circumvention;
from ``adequate ventilation'' the consumer may infer that any addition
of ventilation to the application area, such as opening a window, will
be sufficient to make the
[[Page 12257]]
product safe for indoor use. Such an inference can lead to overexposure
to DCM-containing vapors, potentially resulting in death. Similarly,
unclear wording, such as, ``use in enclosed areas may kill you,''
carries the risk of being misread as simply, ``use in enclosed areas,''
because the word ``use'' in this context can be read as a verb, such as
``use this product,'' rather than read as a noun, such as ``use of this
product,'' and because the consumer may stop reading the statement
before reaching ``may kill you.''
---------------------------------------------------------------------------
\19\ Wogalter et al., 1999.
---------------------------------------------------------------------------
To increase the likelihood of consumers heeding a warning despite
inconveniences imposed by necessary precautions, the phrasing of
warning information should be vivid and relatable.\20\ The Commission
recommends using the phrase ``can kill you,'' as opposed to wording
like: ``may cause death.'' These phrases have the same denotation;
however, the impact on the reader can be different in meaningful ways.
The Commission believes lethality is more salient with the statement
``can kill you'' because it is more personalized, directing the hazard
toward the user, rather than as a possibility for users, in general.
Evidence suggests that emotional communications, especially those that
are fear-based, can be used to increase risk perceptions and change
behaviors; and stronger fear-arousing conditions may lead to greater
message acceptance.\21\
---------------------------------------------------------------------------
\20\ Murray-Johnson, L., & Witte, K. (2003). Looking toward the
future: Health message design strategies. In T.L. Thompson, A.
Dorsey, K.I. Miller, & R. Parrot (Eds.), Handbook of health
communication (pp.473-495). New York City, NY: Routledge.
\21\ Food and Drug Administration, 2011.
---------------------------------------------------------------------------
4. Effect of Consumer Experience With Product
Warning information can be formatted in a way that is noticeable,
more likely to be read, understood, and motivating, and yet remain
unheeded. Research indicates that consumers who are familiar or
experienced with a product are less likely to search for and comply
with warnings.\22\ Paint strippers containing DCM have been around for
decades, and incident data show that these products are sometimes
applied indoors, such as in bathrooms, basements, and closets. The
Commission believes that it is foreseeable that some consumers will
continue to use these products indoors, despite warnings against using
them in enclosed areas because of past incident-free experience with
indoor use of stripping products containing DCM. Therefore, the
Commission suggests including precautions for indoor use as well.
However, because providing precautions for indoor use may mislead some
consumers to believe it is safe to use DCM-based products indoors, the
Commission recommends that the language and format of the safety
information clarify that use in enclosed areas is dangerous, even with
precautions, and should be avoided, if possible. The examples provided
specify that indoor use is dangerous, and they employ repetition and
capitalization to reinforce the point that paint-stripping products
containing DCM should be used outdoors in open air areas.
---------------------------------------------------------------------------
\22\ Wogalter et al., 1999.
---------------------------------------------------------------------------
B. Principal Display Panel (PDP) Minimum Labeling Recommendations
This section provides recommendations for labeling paint stripping
products that contain methylene chloride. The following minimum
labeling recommendations for the PDP meet the requirements of the FHSA.
There are wide variations in the concentrations of methylene chloride
in paint strippers. The precise labeling used may vary based on DCM
concentration, anticipated duration of exposure, and other associated
hazards.
The labels for all products subject to the FHSA are expected to
comply with the requirements for prominence, placement, and
conspicuousness of labeling required by section 2(p)(1) of the FHSA.
The FHSA provides that required labeling statements may be placed on
the PDP, or front panel, on the immediate container, and, if
appropriate, on any other container or wrapper. The appropriate signal
word (i.e., ``DANGER,'' ``WARNING,'' or ``CAUTION) and the statement of
principal hazard[s] are required to be on the PDP. The other items of
required labeling may be placed on some other display panel on the
container, provided that the front panel contains the statement: ``Read
carefully other cautions on the [other display] panel,'' or its
practical equivalent.
The Commission recommends ``WARNING'' as the signal word
for the label. Given cases of lethal exposure to DCM in household
products, the Commission considered the signal word ``DANGER'';
however, the current DCM toxicity data do not meet the FHSA definition
of ``highly toxic,'' which is required for use of the the signal word
``DANGER.''
When providing affirmative statements of all principal
hazards, the Commission recommends stating: ``INHALATION OF VAPOR VERY
HARMFUL,'' followed by: ``VAPOR CAN KILL YOU IN ENCLOSED AREAS.''
Example From 1987 Statement of Cautionary Labeling To Be Included on
the PDP \23\
---------------------------------------------------------------------------
\23\ Given the previously limited data on the acute toxicity of
overexposure to DCM, the Commission believed this labeling to meet,
and in certain respects exceed, the minimum requirements of section
2(p)(1) of the FHSA.
---------------------------------------------------------------------------
In 1987, the Steering Committee for Methylene Chloride, a group of
industry and consumer-interest representatives working with Commission
staff, recommended the following labeling for the PDP for products,
such as some paint strippers that contain high percentages of DCM:
CAUTION: Vapor Harmful, Read Other Cautions and HEALTH HAZARD
INFORMATION on Back Panel
In the 1987 Statement, the Commission presented this labeling for
the PDP as an example that would meet or exceed the minimum
requirements of the FHSA.
Updated Example of Cautionary Labeling
In recognition of updated data on acute health risks of DCM use,
the Commission recommends replacing the 1987 example of cautionary
labeling to be included on the PDP with the information and format
below:
WARNING: INHALATION OF VAPOR VERY HARMFUL VAPOR CAN KILL YOU IN
ENCLOSED AREAS EYE AND SKIN IRRITANT. Read All Cautions on Back/Side
Panel.
The format in the updated PDP example uses capital letters,
repetition, and personalized language to draw attention to the most
severe hazard: Death from inhalation of vapor in enclosed areas. The
repetition of ``vapor'' between the first and second lines aids in
communicating the source and medium by which the hazard presents
itself. The inclusion of ``vapor very harmful'' satisfies the
declaration of both the acute and the chronic hazard. When a chronic
hazard exists, the additional risk of cancer should be included on the
back or other panel, as appropriate under the FHSA. The last line
directs the consumer to the back or other panel, which provides
detailed precautionary information.
C. Back or Other Panel
1. Back or Other Panel Minimum Labeling Recommendations
The Commission recommends the following information and formatting
for the back or other panel of paint stripping products containing DCM.
[[Page 12258]]
These recommendations cover both acute and chronic hazards. Again, the
statements may vary based on the concentration of DCM, anticipated
duration of exposure, and other associated hazards.
The Commission recommends use of ``WARNING'' as the signal
word for the label.
The Commission recommends beginning the precautionary
information by stating, in all capital letters, the lethality of vapor
inhalation and not to use the product in enclosed areas.
The FHSA requires disclosure of all principal hazards. The
Commission recommends disclosing the acute and chronic hazards from
most-to-least severe. Similarly, when symptoms are mentioned, the
Commission recommends it would be most effective to state symptoms from
most-to-least severe.
Because overexposure to DCM may be sudden and can inhibit
the user's capability to notice and react to the effects, the
Commission recommends indicating in all capital letters that symptoms
may not be noticeable.
The Commission recommends separating precautionary
statements by bullet points, if paragraph formatting is used, to aid
visual distinction between precautions.\24\
---------------------------------------------------------------------------
\24\ See the ``Recommended Language Approved by Ad Hoc Task
Group, Revision C'' document dated November 10, 2017, published in
the ``Committee Documents'' section of the Committee F15 ASTM
website.
---------------------------------------------------------------------------
The Commission believes it will be helpful to provide
specific examples of spaces in which the product should not be used,
beginning with bathrooms, basements, and closets because these
locations are particularly dangerous and have been cited in incident
data.
When indicating precautions to be taken, the Commission
recommends stating in all capital letters that the product should be
used outdoors in an open-air area.
The Commission recommends including precautionary
information for indoor use, accompanied by language stating that indoor
use is dangerous even when precautions are taken.
The Commission recommends prohibiting foreseeable
inappropriate actions, such as use of a dust mask to provide protection
against vapors.\25\
---------------------------------------------------------------------------
\25\ A dust mask does not provide effective protection against
overexposure to vapors containing DCM.
---------------------------------------------------------------------------
When providing instructions for first-aid, the Commission
recommends listing in order of the likelihood of occurrence, the types
of exposures and placing each exposure route on a separate line to aid
DCM users in an urgent situation.
2. Example of Updated Safety Information To Be Included on the Back or
Other Panel
In recognition of updated data on acute health risks of DCM use,
the Commission recommends replacing the 1987 example of labeling to be
included on the back or other panel, with the information and format
below:
WARNING Contains Methylene Chloride. INHALATION OF VAPOR CAN
KILL YOU. DO NOT USE IN ENCLOSED AREAS, such as bathrooms,
basements, or closets. SYMPTOMS MAY NOT BE NOTICEABLE. [ssquf] Avoid
contact with eyes or skin, as severe irritation can occur. [ssquf]
Methylene Chloride may cause cancer. [ssquf] The risk to your health
depends on the level and duration of exposure. [ssquf] Keep out of
the reach of children.
SAFETY DIRECTIONS: [ssquf] USE OUTDOORS IN AN OPEN AIR AREA. It
is dangerous to use this product indoors. [ssquf] If you must use
indoors, cross-ventilate work area by opening all windows and doors
and circulating fresh air through the work area to reduce vapor
accumulation. [ssquf] Always wear chemical-splash goggles and
chemical-resistant gloves when handling this product. [ssquf] A dust
mask does not provide protection against the vapors.
FIRST-AID:
INHALATION: First move person to fresh air. If not
breathing, give artificial respiration. Call 911, or poison control
center, or emergency room.
EYE EXPOSURE: Immediately flush affected eye(s) with
water. Call 911, or poison control center, or emergency room, as
soon as possible.
SKIN EXPOSURE: Immediately wash skin with soap and
water. Avoid spreading material on unaffected skin. Remove
contaminated clothing and shoes, and thoroughly clean before reuse.
Contact medical professional for advice.
IF SWALLOWED: IMMEDIATELY call 911, or poison control
center, or emergency room. Do NOT induce vomiting, unless directed
to do so by medical personnel. Never give anything by mouth to an
unconscious person.
In the preceding updated back or other panel example, the most
important safety information is capitalized to attract the consumer's
attention; i.e., if the consumer only reads the capitalized words, his/
her focus is drawn to the following information: Inhaling the vapor can
be deadly; the product should not be used in enclosed areas; symptoms
of overexposure may go unnoticed; and the product should be used
outdoors. Bullet points are used to aid visual distinctions among
precautions. The presentation of the hazards from most-to-least severe,
coupled with the statement that symptoms may go unnoticed, helps to
dismiss the false expectation that the consumer can wait for noticeable
symptoms before taking appropriate precautions or escaping from a
potentially lethal-use scenario. Steps for inhibiting vapor
accumulation indoors are included in the back or other panel,
subsequent to reiteration that household products containing DCM should
be used outdoors and that indoor use is dangerous. The instructions for
first-aid are adapted from OSHA's Chemical Database.\26\ The
instructions are listed in order of the likelihood of exposure route
per incident data. Types of exposure are capitalized and addressed on
separate lines for ease of access to the information in a hurried
state. The company's toll-free number is provided for consumers to seek
more information about appropriate use and first-aid.
---------------------------------------------------------------------------
\26\ OSHA Occupational Chemical Database for Methylene Chloride:
https://www.osha.gov/chemicaldata/chemResult.html?recNo=572,
accessed on December 8, 2017.
---------------------------------------------------------------------------
VI. Implementation of This Guidance
In this update of the 1987 Statement, the Commission provides
guidance to industry on determining the appropriate cautionary labeling
for paint-stripping products that contain DCM. This guidance also
provides examples of statements to convey the hazards associated with
the product. This guidance does not set forth language for particular
products; nor does it specify placement of this language. However, this
document does provide guidance on the factors to consider in developing
the cautionary statements, and it gives examples that satisfy the FHSA.
The level of hazard varies, based on the formulation of the product,
the concentration of DCM, and the customary and reasonably foreseeable
use of the product. If a paint stripper containing methylene chloride
does not appear to be labeled appropriately, Commission staff will
provide guidance to firms and assist firms with labeling their
products.
Under the FHSA, manufacturers are responsible for determining
whether their methylene chloride-containing products meet the
definition of a ``hazardous substance,'' and bear the appropriate
cautionary statements. This determination is based on the concentration
of methylene chloride, the use of the product, and whether the product
presents a significant exposure to methylene chloride vapor with
customary and reasonably foreseeable use. This update of the 1987
Statement provides guidance to manufacturers who must determine the
appropriate labeling for their paint stripper products that contain
methylene chloride. In any enforcement action, Commission staff would
consider on a case-by-case basis
[[Page 12259]]
whether the product's labeling meets the requirements of the FHSA.
VII. Effect on State and Local Laws
In general, the preemption language in section 18(b)(1)(A) of the
FHSA provides that if a hazardous substance or its packaging is subject
to a cautionary labeling requirement under the FHSA designed to protect
against a risk of illness or injury associated with the substance, no
State or political subdivision of a State may establish or continue in
effect a cautionary labeling requirement applicable to a hazardous
substance or packaging that is designed to protect against the same
risk of illness or injury, unless the cautionary labeling requirement
is identical to the labeling requirement under the FHSA. 15 U.S.C.
1261n. As mentioned, this document provides guidance to industry. This
guidance does not have binding legal force, does not constitute a rule,
and thus, does not have preemptive effect. However, the underlying duty
to label a hazardous household product arises from the FHSA. This
underlying statutory obligation preempts state and local non-identical
cautionary labeling requirements that are designed to protect against
the same risk of injury or illness.
Alberta E. Mills,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2018-05580 Filed 3-20-18; 8:45 am]
BILLING CODE 6355-01-P